Why Bremen?

Due to its socio-economic and cultural diversity, Bremen is an ideal location for the development and testing of prevention concepts. This diversity makes it possible to develop approaches that are tailored to different population groups and broadly anchored in society. This is an important basis for transferring them to other regions after adapting them to the respective population structure. The fact that Bremen is a small federal state also proves to be favorable for this type of research. The “short distances” simplify the exchange with politicians and other players in the healthcare system, which is essential in terms of feasibility and sustainability.

In addition, Bremen offers a distinctive research landscape and sound expertise in the fields of epidemiology, prevention and implementation research, which create optimal conditions for the model region:

  • Extensive experience in conducting large epidemiological studies covering the life course from childhood (IDEFICS/I.Family) to adulthood and retirement (NAKO Health Study).
  • Pioneering role in researching the influence of contextual factors on behavior change, supported by innovative technologies. One example for this is the AEQUIPA project, which has focused on promoting physical activity among older people.
  • Leibniz ScienceCampus Digital Public Health Bremen, which offers very good opportunities to research the potential of digital solutions such as health apps.
  • Excellent networking in the field of prevention research, both nationally and internationally, e.g. through BIPS's role as a WHO Collaborating Centre, its participation in the joint actions (EU4Health Programme) PreventNCD and EuCanScreen as well as CPE.
  • Leibniz Living Lab:Real-world laboratory for interaction with the population and the joint development of citizen-oriented interventions. It was set up by BIPS and is located in a very diverse and highly disadvantaged neighborhood in Bremen.
  • Access to databases: The BIPS-based GePaRD claims database covers the majority of Bremen's population. GePaRD contains data since 2004 and can therefore be used both for an inventory and for the assessment of intervention effects. In addition, Bremen has a cancer registry that has been established for decades with high data quality and - unlike most other federal states - also has a so-called mortality index.

These factors make Bremen an ideal location for the development and testing of prevention concepts that are both scientifically sound and feasible in practice.